What's New
Read about what's new in the Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's Hospital Medical Center:
Cincinnati Children's Dedicates New Research Facility
On Monday, Nov. 19, a dedication ceremony was held for the medical center's new 12-story, 415,000-square-foot research building, also known as Location S. Said Jim Anderson, president and CEO, "The name of the building doesn't even hint at our hopes for what will be accomplished inside it. But I can assure you, our aspirations and expectations are high." Read full story and view photos.
Back to Top
CURED Foundation Raises $80,000 for Eosinophilic Disorders Research
On May 6, 2007, The CURED Foundation held CURED Day at the Races, a fund-raising event where more than 300 people turned out for a great afternoon of horse racing and a great cause. The event raised $80,000 to support the research of Marc Rothenberg, MD. Read more about this successful event.
Back to Top
Illinois Senate Bill 935 Passed by the House
Senate Bill 935 passed the Illinois House with an overwhelming majority. This bill requires insurance coverage for amino acid based elemental formulas regardless of delivery method for the diagnosis and treatment for eosinophilic disorders and short bowel syndrome. It will now go back to the Senate for a vote of concurrence – meaning they agree with the changes made by the House. Once it passes the vote of concurrence, the final bill will go on to the governor for his signature to become law. View the full text of the bill.
Back to Top
Congress Declares the Third Week of May Eosinophil Awareness Week
The United States Congress has declared the third week of May to be National Eosinophils Awareness Week. In a bill passed on Tuesday, May 15, 2007 – House Resolution 296 – the third week of May has been identified as an appropriate time to educate communities across the nation about eosinophilic disorders and the need for research funding, accurate diagnosis and effective treatments. The bill was sponsored by the American Partnership for Eosinophilic Disorders -- a non-profit advocacy organization for those living with eosinophilic disorders.
Learn more about the legislation that lead to Eosinophils Awareness Week
Back to Top
CCED Director Named to Prestigious NIH Advisory Panel
Marc Rothenberg, MD, PhD, director of the Cincinnati Center for Eosinophilic Disorders, has been invited to serve on the National Institute of Allergy and Infectious Diseases (NIAID) Council of the National Institutes of Health. The NIAID council advises the Secretary of Health and Human Services, as well as the assistant secretary, the director of the NIH and the director of the NIAID, on matters relating to the conduct and support of research, training and health information dissemination. Dr. Rothenberg is among 18 members of the advisory council who will be responsible for final review and approval of nearly all extramural grants supported by the NIAID. Learn more about this prestigious appointment.
Back to Top
Sean Jameson Rejoins the CCED Team
The Cincinnati Center for Eosinophilic Disorders (CCED) is pleased to welcome back Mr. Sean Jameson as the new program coordinator. Sean previously worked for the CCED during its formative stage, helping coordinate the delivery of patient care and supervising clinical research programs. As the CCED Program Coordinator, Sean will be responsible for the overall function of the CCED including organization of patient services, coordination of scheduling, communication, and the integration top research with outstanding clinical care.
Sean returns to Cincinnati Children's from The Children's Hospital of Philadelphia, where he worked as a clinical research coordinator for the Cancer Survivorship Program in the Division of Oncology. Sean is also an active volunteer in the community. Currently, he volunteers as a group facilitator for Peter's Place: A Center for Grieving Children and Families in Radnor, PA, where he helps parent groups who have lost a spouse. He has also volunteered for the Fernside Center for Grieving Children in Cincinnati. Please join us in giving Sean a warm welcome back to Cincinnati Children's. We're delighted to have him re-join our team!
Back to Top
Eosinophils May Play Role in Asthma Symptoms
Cincinnati scientists have found further evidence that certain defensive white cells in the body cause or play a major role in asthma symptoms. These findings could help identify a new treatment target to help asthma sufferers. Read full story about the findings from this research study on eosinophils. View full story with photos by downloading American Health Center Findings in portable document format (.pdf).
Back to Top
First International Gastrointestinal Eosinophilic Research Symposium (FIGERS)
Join basic and clinical scientists from around the world at the First International Gastrointestinal Eosinophilic Research Symposium (FIGERS) as they present cutting edge research on eosinophilic diseases. This committee is a new NIH-funded subcommittee of the North American Society for Pediatric Gastroenterology, Hepatology, & Nutrtion. At this first annual symposium, investigators and clinicians will present diagnostic guidelines for eosinophilic esophagitis, build interest among young investigators and develop a research agenda for future collaborative studies. Learn more.
Back to Top
CURED Foundation Supports Research for Eosinophilic Disorders
On April 24, 2006, the CURED Foundation presented another donation to the Cincinnati Center for Eosinophilic Disorders in the amount in 85,000, making the total amount donated by CURED $300,000 to date.
CURED, a non-profit organization, was founded by Ellyn and Fred Kodroff, when their daughter, Jori, was diagnosed with an eosinophilic disease at the age of 10. Determined to help their daughter and others suffering from these disorders, they bravely set out to raise money to find a cure. Overwhelmed by support from the community, they soon founded CURED, Campaign Urging Research for Eosinophilic Disease.
Read more about CURED and their past donations to the Cincinnati Center for Eosinophilic Disorders (CCED).
Back to Top
Gene Associated with Eosinophilic Esophagitis Discovered
First gene associated with eosinophilic esophagitis discovered. Learn more.
Researchers at Cincinnati Children's Hospital Medical Center have discovered the first gene associated with eosinophilic esophagitis, one of a number of eosinophil-related diseases in which the body produces abnormally large amounts of white blood cells that can lead to allergy related illnesses. Learn more.
Back to Top
